Free Trial

BriaCell Therapeutics (BCT) News Today

BriaCell Therapeutics logo
C$10.60 -0.42 (-3.81%)
(As of 12/30/2021)
BriaCell Shows Promise in Cancer Immunotherapy Advances
BriaCell’s Promising Breast Cancer Study Results
BCT:CA BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (BCTXW)
Stocks in play: BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. (BCT.TO)
Closing Bell: Briacell Therapeutics Corp up on Tuesday (BCT)
BriaCell Therapeutics (BCT) Initiated with a Buy at H.C. Wainwright
BriaCell CEO Letter to Shareholders
BCTX: SITC Poster Presentation
Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter.

[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

BCT Media Mentions By Week

BCT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCT
News Sentiment

0.00

0.47

Average
Medical
News Sentiment

BCT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCT Articles
This Week

1

0

BCT Articles
Average Week

Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (CVE:BCT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners